Table 2.
As species | Minimum | 25th percentile | Median | 75th percentile | Maximum | IQR | Mean ± SD |
---|---|---|---|---|---|---|---|
EUC (pg As/10,000 cells) | |||||||
iAsIII | < LODa | 2.08 | 8.18 | 17.69 | 1,807 | 15.61 | 24.06 ± 103.0 |
MAsIII | < LOD | 0.45 | 1.78 | 4.04 | 151.7 | 3.59 | 4.17 ± 11.22 |
DMAsIII | < LOD | 0.16 | 0.41 | 1.54 | 141.3 | 1.38 | 2.73 ± 9.58 |
iAsV | < LOD | 1.27 | 4.53 | 22.66 | 728.7 | 21.39 | 34.79 ± 86.26 |
MAsV | < LOD | 0.19 | 0.85 | 5.08 | 776.2 | 4.89 | 13.11 ± 53.48 |
DMAsV | < LOD | 0.66 | 1.90 | 13.82 | 2,303 | 13.16 | 49.18 ± 200.7 |
iAsIII + V | 0.36 | 6.35 | 17.13 | 41.11 | 2,148 | 34.76 | 58.52 ± 155.2 |
MAsIII + V | 0.04 | 1.12 | 3.14 | 9.84 | 803.3 | 8.72 | 17.25 ± 57.87 |
DMAsIII + V | 0.04 | 0.88 | 2.41 | 15.83 | 2,366 | 14.95 | 51.91 ± 208.9 |
Sum of As speciesb | 0.78 | 10.05 | 25.50 | 76.3 | 3,773 | 66.25 | 127.7 ± 359.6 |
MAs/iAs | 0.01 | 0.15 | 0.2 | 0.28 | 3.63 | 0.13 | 0.26 ± 0.28 |
DMAs/MAs | 0.04 | 0.55 | 1.10 | 2.90 | 51.47 | 2.35 | 2.15 ± 3.64 |
DMAs/iAs | 0.004 | 0.10 | 0.20 | 0.52 | 35.0 | 0.42 | 0.77 ± 2.5 |
(MAs + DMAs)/iAs | 0.02 | 0.28 | 0.40 | 0.79 | 35.63 | 0.51 | 1.03 ± 2.68 |
Urine (ng As/mL) | |||||||
iAsIII + V | < LOD | 0.98 | 4.62 | 10.21 | 119.2 | 9.23 | 7.3 ± 10.3 |
MAsIII + V | < LOD | 2.23 | 7.34 | 15.97 | 131.1 | 13.74 | 11.1 ± 12.9 |
DMAsIII + V | 0.36 | 13.05 | 40.46 | 82.72 | 307.2 | 69.67 | 55.42 ± 53.8 |
Sum of As species | 0.52 | 17.00 | 53.50 | 108.4 | 492.5 | 91.40 | 73.87 ± 73.24 |
MAs/iAs | 0.10 | 1.28 | 1.64 | 2.11 | 199.4 | 0.83 | 4.51 ± 18.1 |
DMAs/MAs | 1.73 | 4.09 | 5.19 | 7.06 | 86.2 | 2.97 | 6.25 ± 5.27 |
DMAs/iAs | 0.41 | 6.57 | 9.25 | 12.43 | 2,117 | 5.86 | 29.1 ± 142.3 |
(MAs + DMAs)/iAs | 0.51 | 8.07 | 10.94 | 14.47 | 2,317 | 6.40 | 33.58 ± 159.6 |
aThe minimum values were < LOD for iAsIII (n = 3), MAsIII (n = 13), DMAsIII (n = 19), iAsV (n = 6), MAsV (n = 21), or DMAsV (n = 3) in EUC, and for iAsIII + V (n = 15) or MAsIII + V (n = 2) in urine. bSum of As species = iAsV + iAsIII + MAsV + MAsIII + DMAsV + DMAsIII. |